Oral Dydrogesterone in the Management of Preterm Labor
Status:
Completed
Trial end date:
2020-05-31
Target enrollment:
Participant gender:
Summary
This study evaluates the addition of oral dydrogesterone to standard treatment in the
treatment of preterm labor. Half of participants will receive oral dydrogesterone and
standard treatment, while the other half will receive oral placebo and standard treatment.